About a year after its founding, the not-for-profit pharma consortium TransCelerate Biopharma Inc. has not only reached the first-year milestones it set for its five clinical trial initiatives, it also has additional milestones in place for 2014 and 2015. Over the same period, TransCelerate has expanded